Trends of Genuv Cancer Drug Show Potential For Alzheimers
Mekinist (trametinib), which has been licenced by the FDA for the treatment of melanoma, was...
Axsome Pitches Auvelity As A Depression Med Game-Changer
It is commonly known that there are insufficient therapy choices for major depressive disorder. Then...
As Vaccine Firms Prep For A Busy Season, Influenza May Hit
Flu season is just around the horizon as the summer draws to a close and...
Gene Therapy By Bluebird Bio Costing $2.8M Given Nod By FDA
Gene therapy for blood disorders developed by Bluebird Bio has already left the nest in...
ADCs Built On Starpharma Delivery Tech To Be Tested By Merck
As it works to expand its antibody-drug conjugate (ADC) capabilities, Merck has strengthened its links...
After Roe, Bayer Engages Lobbyists For Contraception Access
While a large portion of the biopharma industry prepares for a battle over medication prices,...
Trodelvy Wins A Battle Against Breast Cancer With Gilead
Gilead staked money on Trodelvy providing a life-extension benefit when it failed to show promise...
Study Uncovers And Exploits Flaws In Some High-Risk Cancers
A team of researchers led by C. Patrick Reynolds, M.D., Ph.D., director of the Texas...
Nasal Administration Could Boost HIV And COVID-19 Vaccines
A team led by an assistant professor from the University of Minnesota in the US has...
Enhertu From AZ, Daiichi Sankyo Now Has The FDA Approval
With two significant FDA clearances in as many weeks, Enhertu from AstraZeneca and Daiichi Sankyo...
